Overview This page contains the latest trade data of Phenazone (antipyrin), derivatives. In 2023, Phenazone (antipyrin), derivatives were the world's 3966th most traded product, with a total trade of $122M. Between 2022 and 2023 the exports of Phenazone (antipyrin), derivatives decreased by -17%, from $147M to $122M. Trade in Phenazone (antipyrin), derivatives represent 0.00054% of total world trade.
Phenazone (antipyrin), derivatives are a part of Nitrogen Heterocyclic Compounds.
Exports In 2023 the top exporters of Phenazone (antipyrin), derivatives were China ($58.6M), Germany ($46.7M), India ($5.92M), France ($3.16M), and United Kingdom ($1.48M).
Imports In 2023 the top importers of Phenazone (antipyrin), derivatives were Brazil ($21.5M), Romania ($14.7M), Germany ($8.86M), Spain ($8.66M), and Bulgaria ($7.37M).
Ranking Phenazone (antipyrin), derivatives ranks 832nd in the Product Complexity Index (PCI).
Description Phenazone (antipyrin) is used to treat fever and pain. It was developed in 1912 by the German scientist Heinrich H. E. Backer, and was originally marketed as "Novocaine."